Tests a combined pill for high blood pressure and high cholesterol
Tests a combined drug treatment in adults with high blood pressure and high cholesterol.
Key facts
- Who runs it
- JW Pharmaceutical
- Where
- Seoul, South KoreaSee the site
- Trial code
- Registry title
- Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 162 people, planned
- Started
- 2 Dec 2024
- Planned end
- Apr 2026
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- JW0104+C2402
- JW0104+C2403
- C2402
- Record updated
- 9 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with both high blood pressure and abnormal blood fats (dyslipidemia). It tests two medicines taken together.
- Age
- 19 years or older
- Sex
- Men and women can join.
- Disease stage
- High blood pressure together with dyslipidemia. The blood pressure and LDL cholesterol levels must meet the levels set by the trial.
- Biomarker or test result
- Blood pressure (msBP) and LDL-C levels must meet the levels set by the trial.
Main reasons for not taking part
- People whose blood pressure (msBP) and LDL-C levels do not meet the levels set by the trial cannot join.
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Patients with hypertension and dyslipidemia
Who cannot take part
- The subject not meet the specified msBP and LDL-C level
Where in South Korea
- Gangdong Sacred Heart HospitalSeoul, South KoreaContact: Minjung KimTaking people
About the trial
What the trial wants to find out
A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients with Hypertension and Dyslipidemia
The 3 groups in the trial
- JW0104+C2402Treatment being tested
JW0104+C2402, 8 weeks, QD (Quaque Die)
- JW0104+C2403Existing treatment, for comparison
JW0104+C2403, 8 weeks, QD
- C2402Existing treatment, for comparison
C2402, 8 weeks, QD
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
- Plain-language title
- Tests a combined pill for high blood pressure and high cholesterolGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 9 September 2025